Genedx Holdings Corp Stock In The News

WGS Stock   80.46  1.75  2.22%   
Our overall analysis of GeneDx Holdings' news coverage and content from conventional and social sources shows investors' bearish mood towards GeneDx Holdings Corp. The specific impact of GeneDx Holdings news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of GeneDx Holdings' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using GeneDx Holdings headlines in addition to utilizing other, more conventional financial analysis modules. Check out GeneDx Holdings Backtesting and GeneDx Holdings Hype Analysis.

GeneDx Holdings Today Top News and Investor Outlook

Yahoo News
20 Most Valuable Digital Health Companies In The US
https://finance.yahoo.com/news/20-most-valuable-digital-health-101514258.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
https://www.globenewswire.com/news-release/2023/11/28/2787358/0/en/GeneDx-to-Participate-in-6th-Annual-Evercore-ISI-HealthCONx-Conference.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/11/20/2783595/0/en/GeneDx-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights
https://www.globenewswire.com/news-release/2023/10/30/2769667/0/en/GeneDx-Reports-Third-Quarter-2023-Financial-Results-and-Business-Highlights.html
 Neutral
Macroaxis News: globenewswire.com
GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023
https://www.globenewswire.com/news-release/2023/10/09/2757022/0/en/GeneDx-to-Report-Third-Quarter-2023-Financial-Results-on-Monday-October-30-2023.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/09/22/2748179/0/en/GeneDx-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Announces Evolution of Executive Leadership Team
https://www.globenewswire.com/news-release/2023/09/11/2740763/0/en/GeneDx-Announces-Evolution-of-Executive-Leadership-Team.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced
https://www.globenewswire.com/news-release/2023/09/06/2738339/0/en/GeneDx-Announces-Industry-Leading-Accomplishment-of-500-000-Clinical-Exomes-Sequenced.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Announces Data Demonstrating that...
https://www.globenewswire.com/news-release/2023/08/21/2728540/0/en/GeneDx-Announces-Data-Demonstrating-that-Whole-Exome-and-Genome-Sequencing-Report-Fewer-Variants-of-Uncertain-Significance-VUS-than-Multi-Gene-Panel-Testing-Published-in-Genetics-i.html
 Bullish
Macroaxis News: globenewswire.com
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/08/09/2721267/0/en/GeneDx-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish

GeneDx Holdings Corp Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide GeneDx and other traded companies coverage with news coverage. We help investors stay connected with GeneDx headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on GeneDx Stock performance. Please note that trading solely based on the GeneDx Holdings Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
GeneDx Holdings' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help GeneDx Holdings Corp investors visualize upcoming and past events in order to time the market based on GeneDx Holdings Corp noise-free hype analysis.
GeneDx Holdings stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the GeneDx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about GeneDx Holdings that are available to investors today. That information is available publicly through GeneDx media outlets and privately through word of mouth or via GeneDx internal channels. However, regardless of the origin, that massive amount of GeneDx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GeneDx Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GeneDx Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GeneDx Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GeneDx Holdings alpha.

GeneDx Largest EPS Surprises

Earnings surprises can significantly impact GeneDx Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-15
2022-06-30-0.21-0.25-0.0419 
2023-03-14
2022-12-31-0.16-0.25-0.0956 
2022-03-14
2021-12-31-0.26-0.170.0934 
2024-07-30
2024-06-30-0.3-0.10.266 
2021-11-15
2021-09-30-0.19-0.43-0.24126 
2024-10-29
2024-09-30-0.210.040.25119 
View All Earnings Estimates

GeneDx Holdings Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to GeneDx Holdings Corp Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
businesswire News
22nd of November 2024
Disposition of 60000 shares by Opko Health, Inc. of GeneDx Holdings at 33.8543 subject to ...
at businesswire.com 
Investing News at Macroaxis
20th of November 2024
Mount Sinai Health System sells 10.4 million in GeneDx shares
at investing.com 
Yahoo News
19th of November 2024
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
at finance.yahoo.com 
news
13th of November 2024
40,573 Shares in GeneDx Holdings Corp. Acquired by Chartwell Investment Partners LLC
at thelincolnianonline.com 
Gurufocus Stories at Macroaxis
8th of November 2024
GeneDx Holdings Corp Stock Price Up 5.28 percent on Nov 8
at gurufocus.com 
zacks News
5th of November 2024
Zacks.com featured highlights include Snap, GeneDx and Leonardo
at zacks.com 
businesswire News
4th of November 2024
GeneDx to Highlight Key Research Findings at American Society of Human Genetics Annual Mee...
at businesswire.com 
Gurufocus Stories at Macroaxis
30th of October 2024
GeneDx Holdings Corp Q3 2024 Earnings Call Highlights Record Revenue Growth and First ...
at gurufocus.com 
Gurufocus Stories at Macroaxis
9th of October 2024
GeneDx Holdings Corp Q2 2024 Earnings Call Highlights Strong Revenue Growth and Improved ....
at gurufocus.com 
Gurufocus Stories at Macroaxis
12th of September 2024
Disposition of 897 shares by Saad Kareem of GeneDx Holdings at 9.2095 subject to Rule 16b-...
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GeneDx Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GeneDx Holdings' short interest history, or implied volatility extrapolated from GeneDx Holdings options trading.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.